EPISODE · Feb 3, 2023 · 31 MIN
The Companies and Markets show: Vodafone, GSK and the management merry-go-round
from Investors' Chronicle
On this week's episode, Vodafone is under the spotlight as it's problems in Europe continue. Is there much they can do in the face of big cash flow demands, rising inflation, sluggish growth?Next up it's a trip on the management merry-go-round. Over 20 per cent of FTSE 100 companies changed CEOs last year. Is this just a random datapoint, a sign of post-pandemic fatigue, or perhaps moving out ahead of the higher-rate era? Our panel discusses.Finally it's GSK chat with the IC's pharma writer Jennifer Johnson. With concerns around their Zantac drug, are investors lacking faith in the GSK pipeline?Dan Jones hosts Alex Newman, Julian Hofmann and Jennifer Johnson.Investors' Chronicle has supported private investors in the UK for over 160 years by highlighting rewarding investment opportunities. Investors' Chronicle is a service by the Financial Times. Hosted on Acast. See acast.com/privacy for more information.
Embed this episode
Ready to play
The Companies and Markets show: Vodafone, GSK and the management merry-go-round
No transcript for this episode yet
Similar Episodes
No similar episodes found.